|
National Stock Number(NSN): 6505-01-258-0984 (6505012580984, 012580984)
| NIIN: |
01-258-0984 |
Item Name: |
TERBUTALINE SULFATE TABLETS |
INC: |
34207
|
| FSC: |
6505
|
Assignment Date: |
Jun-27-1987 |
CRIT: |
X |
IIG: |
34207 |
| ISC: |
2 |
Date Standardized: |
Sep-15-1990 |
HMIC: |
P |
DODIC: |
|
| NSC: |
8 |
Cancellation Date: |
Apr-30-2010 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
90-0727 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
BRETHINE |
97423
|
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
BRETHINE TABLETS |
97423
|
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00028-0072-10 |
97423
|
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
|
Q |
U |
1 |
A |
$94.03 |
BT |
|
C2201X- |
Oct-01-2000 |
H |
| DF |
S9M |
H |
|
Q |
U |
1 |
F |
$94.03 |
BT |
|
------- |
Oct-01-2000 |
H |
| DN |
SMS |
Y |
|
Q |
U |
1 |
N |
$94.03 |
BT |
|
9L----- |
Nov-01-2007 |
H |
| DS |
SMS |
Y |
|
Q |
U |
1 |
D |
$94.03 |
BT |
|
------- |
Dec-01-2000 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 1000TT |
000 |
|
|
|
| DA |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 1000TT |
000 |
|
|
|
| DF |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 1000TT |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 1000TT |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.500 MILLIGRAMS TERBUTALINE SULFATE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1000.000 TABLETS |
| THPE |
THERAPEUTIC EQUIVALENT |
BRETHINE BY CIBA-GEIGY PHARMACEUTICALS |
|